Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Clinical trial NCT01310413 · COMPLETED

Trial details

NCT number: NCT01310413
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Influenza Vaccines

Start date: 2011-03-07
Primary completion: 2011-07-21
Enrollment: 842

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.